Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

ESMO Preceptorship on Non-Small-Cell and Small-Cell Lung Cancer 2024: Singapore

09 - 10 Dec 2024

Singapore, Republic of Singapore

ESMO-Preceptorship-Lung-Cancer-1000x1000

Slides and Webcasts from all ESMO Preceptorships are reserved to ESMO Members and registered participants, according to the presenters' agreement to release them. ESMO thanks the authors for their generosity.

The copyright protected educational resources from this event are for personal usage only and not to be shared with any third parties.

Meeting programme Next/upcoming meetings

Learning objectives

To learn about best clinical practice in the management of NSCLC in early, locally advanced and metastatic stages
To learn about the management of patients with actionable driver alterations and novel targeted agents for advanced NSCLC
To understand the role of immune checkpoint blockade for lung cancer and to learn about novel immunotherapies
To learn about the systemic treatment of SCLC

This event has been supported by an unrestricted educational grant from Amgen and MSD.

Hide

There are 21 resources available